Homing of endogenous stem/progenitor cells for in situ tissue regeneration: Promises, strategies, and translational perspectives

被引:381
作者
Chen, Fa-Ming [1 ,2 ]
Wu, Li-An [2 ,3 ]
Zhang, Min [4 ]
Zhang, Rong [5 ]
Sun, Hai-Hua [5 ]
机构
[1] Fourth Mil Med Univ, Sch Stomatol, Dept Periodontol & Oral Med, Xian 710032, Shaanxi, Peoples R China
[2] Fourth Mil Med Univ, Sch Stomatol, Translat Res Grp, Xian 710032, Shaanxi, Peoples R China
[3] Fourth Mil Med Univ, Sch Stomatol, Dept Paediat Dent, Xian 710032, Shaanxi, Peoples R China
[4] Fourth Mil Med Univ, Sch Stomatol, Dept Gen Dent & Emergency, Xian 710032, Shaanxi, Peoples R China
[5] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, Xian 710032, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Cell homing; Tissue engineering; Endogenous regenerative technology; Biomimetic design; Drug delivery; Translational medicine; MESENCHYMAL STEM-CELLS; ENDOTHELIAL PROGENITOR CELLS; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-DELIVERY; BONE-MARROW-CELLS; ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CONTROLLED-TRIAL; IMPROVES CARDIAC-FUNCTION; NEURAL STEM; PERIODONTAL-LIGAMENT;
D O I
10.1016/j.biomaterials.2010.12.032
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
Stem cell-based therapy has been one of the best documented approaches in regenerative medicine, promising cures for a multitude of diseases and disorders. However, the ex vivo expansion of stem cells and their in vivo delivery are restricted by the limited availability of stem cell sources, the excessive cost of commercialization, and the anticipated difficulties of clinical translation and regulatory approval. An alternative to adoptively transferred stem cells are cell populations already present in a patient's body, including stem/progenitor cells, which can be actively attracted to sites of injury. This technique, known as endogenous cell homing, has the potential to provide new therapeutic options for in situ tissue regeneration. Such options would be less costly and complex than approaches that require substantial ex vivo cell manipulation and that use artificial vehicles for cell delivery. Tissue regeneration methods that rely on endogenous stem/progenitor cell homing, local tissue responses, and functional stimulation thus offer new insights into in vivo tissue engineering and hold great promise for the future of translational medicine. Although such methods that take advantage of the latent endogenous regenerative potential of the patient are promising for the repair of damaged tissue, they are in need of further experimental support before application in late-stage diseases or severe tissue injury. This review is not meant to be exhaustive but gives a brief outlook on the promises, strategies, and current applications of endogenous stem cell homing for in situ tissue regeneration, with particular emphasis placed upon pharmacological means based on cell-instructive scaffolds and release technology to direct cell mobilization and recruitment. In the future these exciting paradigms are likely to help reconcile the clinical and commercial pressures in regenerative medicine. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3189 / 3209
页数:21
相关论文
共 239 条
[61]
Facilitated endogenous repair: making tissue engineering simple, practical, and economical [J].
Evans, Chris H. ;
Palmer, Glyn D. ;
Pascher, Arnulf ;
Porter, Ryan ;
Kwong, Francois N. ;
Gouze, Elvire ;
Gouze, Jean-Noel ;
Liu, Fangjun ;
Steinert, Andre ;
Betz, Oliver ;
Betz, Volker ;
Vrahas, Mark ;
Ghivizzani, Steven C. .
TISSUE ENGINEERING, 2007, 13 (08) :1987-1993
[62]
Nonhuman primate allogeneic hematopoietic stem cell transplantation by intraosseus vs intravenous injection: Engraftment, donor cell distribution, and mechanistic basis [J].
Feng, Qi ;
Chow, Pierce K. H. ;
Frassoni, Francesco ;
Phua, Cindy M. L. ;
Tan, Peik K. ;
Prasath, Arun ;
Hwang, William Ying Khee .
EXPERIMENTAL HEMATOLOGY, 2008, 36 (11) :1556-1566
[63]
Homing of lin-/CD117+ hematopoietic stem cells [J].
Filip, Stanislav ;
Mokry, Jaroslav ;
Vavrova, Jirina ;
Cizkova, Dana ;
Sinkorova, Zuzana ;
Tosnerova, Vlasta ;
Blaha, Milan .
TRANSFUSION AND APHERESIS SCIENCE, 2009, 41 (03) :183-190
[64]
The selective modulation of endothelial cell mobility on RGD peptide containing surfaces by YIGSR peptides [J].
Fittkau, MH ;
Zilla, P ;
Bezuidenhout, D ;
Lutolf, M ;
Human, P ;
Hubbell, JA ;
Davies, N .
BIOMATERIALS, 2005, 26 (02) :167-174
[65]
Tissue engineering and cell based therapies, from the bench to the clinic: The potential to replace, repair and regenerate [J].
William L Fodor .
Reproductive Biology and Endocrinology, 1 (1)
[66]
Stem cell homing in musculoskeletal injury [J].
Fong, Eliza L. S. ;
Chan, Casey K. ;
Goodman, Stuart B. .
BIOMATERIALS, 2011, 32 (02) :395-409
[67]
Can hematopoietic stem cells be an alternative source for skin regeneration? [J].
Fu, Xiaobing ;
Sun, Xiaoyan .
AGEING RESEARCH REVIEWS, 2009, 8 (03) :244-249
[68]
CXCR4 and cancer [J].
Furusato, Bungo ;
Mohamed, Ahmed ;
Uhlen, Mathias ;
Rhim, Johng S. .
PATHOLOGY INTERNATIONAL, 2010, 60 (07) :497-505
[69]
Self-Assembling Peptide Amphiphile Nanofibers as a Scaffold for Dental Stem Cells [J].
Galler, Kerstin M. ;
Cavender, Adriana ;
Yuwono, Virany ;
Dong, He ;
Shi, Songtao ;
Schmalz, Gottfried ;
Hartgerink, Jeffrey D. ;
D'Souza, Rena N. .
TISSUE ENGINEERING PART A, 2008, 14 (12) :2051-2058
[70]
The dynamic in vivo distribution of bone marrow-derived mesenchymal stent cells after infusion [J].
Gao, JZ ;
Dennis, JE ;
Muzic, RF ;
Lundberg, M ;
Caplan, AI .
CELLS TISSUES ORGANS, 2001, 169 (01) :12-20